Search

Your search keyword '"Negri C."' showing total 459 results

Search Constraints

Start Over You searched for: Author "Negri C." Remove constraint Author: "Negri C."
459 results on '"Negri C."'

Search Results

201. Parietal intrahemispheric source connectivity of resting-state electroencephalographic alpha rhythms is abnormal in Naïve HIV patients.

202. [The new Maugeri diagnostic protocol for work-related stress and mobbing (MASD-2)].

203. Dynamic Voltage Restorer (DVR) with a novel robust control strategy.

204. MAPO-18 Catalysts for the Methanol to Olefins Process: Influence of Catalyst Acidity in a High-Pressure Syngas (CO and H 2 ) Environment.

205. The psychological impact of COVID-19 among primary care physicians in the province of Verona, Italy: a cross-sectional study during the first pandemic wave.

206. Structural Elucidation, Aggregation, and Dynamic Behaviour of N,N,N,N -Copper(I) Schiff Base Complexes in Solid and in Solution: A Combined NMR, X-ray Spectroscopic and Crystallographic Investigation.

208. Identification of the Inappropriate Clinical Actions (DON'T) to Improve the Management of Patients with Type 2 Diabetes Failing Basal Insulin Supported Oral Treatment: Results of Survey for a Panel of Diabetes Specialists in Italy.

209. Investigating the role of Cu-oxo species in Cu-nitrate formation over Cu-CHA catalysts.

210. Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12.

211. Work-related post-traumatic stress disorder: report of five cases.

212. Morphology, Surface Structure and Water Adsorption Properties of TiO 2 Nanoparticles: A Comparison of Different Commercial Samples.

213. In vivo silencing of miR-125a-3p promotes myelin repair in models of white matter demyelination.

214. Structure and Reactivity of Oxygen-Bridged Diamino Dicopper(II) Complexes in Cu-Ion-Exchanged Chabazite Catalyst for NH 3 -Mediated Selective Catalytic Reduction.

215. EXAFS wavelet transform analysis of Cu-MOR zeolites for the direct methane to methanol conversion.

216. Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9.

217. The prescribing cascade 3.0: a case for recreational drugs in HIV.

218. Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy.

219. Depressive symptoms and glycaemic control in adults with type 1 diabetes: an exploratory study on the role of family functioning.

220. Enhancing hyper-thermophilic hydrolysis pre-treatment of chicken manure for biogas production by in-situ gas phase ammonia stripping.

221. Effects of Aerobic and Resistance Training on Circulating Micro-RNA Expression Profile in Subjects With Type 2 Diabetes.

222. Genomic Characterization of an ST1153 PVL-producing Methicillin Resistant Staphylococcus aureus Clinical Isolate in Italy.

223. Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods.

224. Investigating the Low Temperature Formation of Cu II -(N,O) Species on Cu-CHA Zeolites for the Selective Catalytic Reduction of NO x .

225. Sex differences in the association of psychological status with measures of physical activity and sedentary behaviour in adults with type 2 diabetes.

226. Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination.

227. Pharmacodynamics of Voriconazole for Invasive Pulmonary Scedosporiosis.

228. Atomic-Scale Front Propagation at the Onset of Frictional Sliding.

229. The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes.

230. The Cu-CHA deNOx Catalyst in Action: Temperature-Dependent NH3-Assisted Selective Catalytic Reduction Monitored by Operando XAS and XES.

232. Metabolic Effects of Exercise.

233. Serum testosterone predicts cardiorespiratory fitness impairment in normal-weight women with polycystic ovary syndrome.

234. Deformation and failure of curved colloidal crystal shells.

235. Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Program.

236. Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).

237. Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes.

238. Cryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in vitro susceptibility to triazoles.

239. Trends in hospital admissions at a Department for Infectious Diseases in Italy from 1995 to 2011 and implications for health policies.

240. Reply: To PMID 23504926.

241. Relationships between cardiorespiratory fitness, metabolic control, and fat distribution in type 2 diabetes subjects.

242. Glycated haemoglobin is inversely related to serum vitamin D levels in type 2 diabetic patients.

243. Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial).

244. Cerebral metastasis from malignant pleural mesothelioma.

245. Inappropriate dose of enteral antimicrobials promotes resistance.

246. Comparison of two creatinine-based estimating equations in predicting all-cause and cardiovascular mortality in patients with type 2 diabetes.

247. Aortic and mitral annular calcifications are predictive of all-cause and cardiovascular mortality in patients with type 2 diabetes.

248. Hyperinsulinemia amplifies GnRH agonist stimulated ovarian steroid secretion in women with polycystic ovary syndrome.

249. Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study).

250. Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function.

Catalog

Books, media, physical & digital resources